Tag: Precision medicine

For the first time, scientists said they reached into the genome of a really sick kid and changed the unique misspelling in his DNA. It was a big deal, like seriously huge, and it...

David Epstein, who previously served as the CEO of Seagen, has launched a new cancer startup called Ottimo Pharma. The company aims to develop a drug that targets two proteins, PD-1 and VEGF, in...

Amgen, Biogen, and Takeda are three biopharma companies facing challenges in developing treatments for obesity and Alzheimer's disease. At the STAT 2024 Summit in Boston, leaders from these companies discussed their research and development...